- BRCA1 and BRCA2 - pathologist's starting kit2016 | Second Faculty of Medicine
- Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers2016 | First Faculty of Medicine
- Options and consequences of genetic testing in patients with high risk of breast and ovarian cancer due to BRCA1 and BRCA2 mutations2015 | Faculty of Medicine in Pilsen
- Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene - Case Report2016 | Second Faculty of Medicine
- Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers2023 | First Faculty of Medicine
- Recommendations for follow-up of cancer patients and healthy carriers with BRCA1 or BRCA2 mutations2003 | Faculty of Physical Education and Sport
- Options of prevention in BRCA1 and BRCA2 mutation carriers2011 | First Faculty of Medicine
- Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum2016 | First Faculty of Medicine, Second Faculty of Medicine
- Testing of mutations in BRCA1 and BECA2 genes in tumor tissues - possibilities and limitations2016 | Faculty of Medicine in Hradec Králové
- Recommendations for follow-up of cancer patients and healthy carriers with BRCA1 or BRCA2 mutations2003 | First Faculty of Medicine
- Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers2010 | First Faculty of Medicine
- Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction2010 | First Faculty of Medicine
- The role of BRCA1 and BRCA2 genes in breast cancer developmentPublication without faculty affiliation
- Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancer2008 | First Faculty of Medicine
- Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancerPublication without faculty affiliation
- Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene2010 | First Faculty of Medicine
- Role of somatic mutations in BRCA1 and BRCA2 genes in sporadic cancer developmentPublication without faculty affiliation
- Mutation analysis of BRCA1 and BRCA2 genes in the hereditary breast and ovarian cancerPublication without faculty affiliation
- Olaparib - the first PARP inhibitor in the treatment of malignant tumors2015 | First Faculty of Medicine
- Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA22023 | First Faculty of Medicine
- BRCA1 and BRCA2 5 ' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding2018 | First Faculty of Medicine
- Hereditary breast cancer - an example of uncommon breast cancer in population2009 | First Faculty of Medicine
- Platinum-sensitive recurrent ovarian cancer and olaparib maintenance treatment - case report2019 | First Faculty of Medicine
- Inactivation of BRCA1 and BRCA2 genes in sporadic breast carcinomaPublication without faculty affiliation
- Screening for germline mutations in BRCA1 and BRCA2 genes in Czech republicPublication without faculty affiliation
- Screening for germline mutations in BRCA1 and BRCA2 genes in Czech republic2001 | Faculty of Physical Education and Sport
- Serous tubal intraepithelial carcinoma2018 | First Faculty of Medicine
- Hereditary breast cancer - new facts2022 | First Faculty of Medicine
- A Rare Truncating BRCA2 Variant and Genetic Susceptibility to Upper Aerodigestive Tract Cancer2015 | First Faculty of Medicine
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic2023 | First Faculty of Medicine